Clinical trial for Deafness
Official title Improving Clinical Efficiency by Reducing Scheduled Follow-ups Using Cochlear America's Population Mean Mapping Strategy
ClinicalTrials.gov ID: NCT06960616
What this study is testing
- What it's testing
- The study wants to see whether reducing the number of follow‑up appointments after a cochlear implant stays safe and effective, and whether a new programming method can give similar results while shortening visits.
- Who it's for
- It is looking for people who have chosen Cochlear Americas for their upcoming cochlear implant surgery and are ready to have the implant activated.
- What's involved
- Participants will have fewer scheduled follow‑up visits after activation and will use Cochlear Americas’ population mean mapping program. They will still receive the implant and have the necessary tests and check‑ups during the reduced visits.
- Time commitment
- The study lasts until the final follow‑up after activation, with a smaller number of appointments than usual; each visit will be shorter than typical appointments.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Postlingually deafened
- Adults (18+)
- New cochlear implant recipients with Cochlear Americas devices; identified prior to activation
- Able to perform follow-up testing tasks (repeating words/sentences, indicating they heard a sound stimulus, completing questionnaires)
- English speakers
You likely can't join if
- Patients who select other cochlear implant manufactured devices
- Pre-lingually deafened
- Multiple disabilities
- Unable to perform follow-up testing tasks (repeating words/sentences, indicating they heard a sound stimulus, completing questionnaires)
- Non-English speakers
- Children under the age of 18
The study team makes the final eligibility decision.
Where it is enrolling
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Boston, Massachusetts, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.